KR950703955A - 테르피리딘 유도체의 약학적 용도 - Google Patents

테르피리딘 유도체의 약학적 용도

Info

Publication number
KR950703955A
KR950703955A KR1019950702396A KR19950702396A KR950703955A KR 950703955 A KR950703955 A KR 950703955A KR 1019950702396 A KR1019950702396 A KR 1019950702396A KR 19950702396 A KR19950702396 A KR 19950702396A KR 950703955 A KR950703955 A KR 950703955A
Authority
KR
South Korea
Prior art keywords
group
pharmaceutical composition
terpyridine derivative
pharmaceutically acceptable
acceptable salt
Prior art date
Application number
KR1019950702396A
Other languages
English (en)
Inventor
히로후사 시라이
켄지 하나부사
유키 타카하시
후미오 미조베
가즈노리 하나다
Original Assignee
우에하라 아키라
다이쇼 세야쿠 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 우에하라 아키라, 다이쇼 세야쿠 가부시키가이샤 filed Critical 우에하라 아키라
Publication of KR950703955A publication Critical patent/KR950703955A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/22—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing two or more pyridine rings directly linked together, e.g. bipyridyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/26—Radicals substituted by halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Abstract

식(Ⅰ)
(식중, R은 수소원자, 치환 또는 비치환 페닐기, 피리딜기 등을 나타낸다)로 표시되는 테르피리딘 유도체는 신경성장인자 작용을 갖는다. 따라서, 예를 들면 외상성, 알코올이나 항암제 등의 약제성, 염증성, 당뇨병 등에서 보여지는 대사성, 나아가서는 특발성 말초성 신경변성에 수반하는 증상, 질환의 개선, 치료제로서 사용될 수 있다. 또한, 중추성 신경변성에 수반하는 증상, 질환, 예를 들면 알츠하이머 형 및 뇌혈관성 치매, 다운증후군, 파킨슨병, 헌팅톤 무답병, 뇌허혈, 뇌경색, 뇌출혈, 두부외상 등에 의해 생기는 정신 및 운동기능 부전증, 척추성 신경마비증 등의 개선·치료제로서도 사용될 수 있다.

Description

테르피리딘 유도체의 약학적 용도
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (6)

  1. 식(Ⅰ)
    [식중, R은 수소원자； 비치환 페닐기； 알킬기, 알콕시기, 히드록시기, 니트로기, 아미노기, 카르복시기, 브로모메틸기, 2-히드록시에톡시기, 2-아세톡시에톡시기 및 할로겐 원자로 이루어진 군으로부터 선택된 적어도 1종의 치환기로 치환된 페닐기； 피리딜기； 또는 하기 식(Ⅱ)-1∼(Ⅱ)-8
    의 어느 하나로 표시되는 관능기를 나타낸다. ] 로 표시되는 테르피리딘 유도체 또는 그의 약리학적으로 허용되는 염을 유효성분으로 함유하는 의약 조성물.
  2. 신경변성질환의 개선 또는 치료용으로 사용되는 제1항 기재의 의약 조성물.
  3. 의약 조성물의 유효성분으로서 사용하기 위한 제1항 기재의 테르피리딘 유도체 또는 그의 약학적으로 허용되는 염.
  4. 신경변성질환의 개선 또는 치료용으로 사용되는 의약 조성물인 제3항 기재의 테르피리딘 유도체 또는 그의 약학적으로 허용되는 염.
  5. 신경변성질환의 개선 또는 치료용 의약 조성물을 제조하기 위한 제1항 기재의 테르피리딘 유도체 또는 그의 약학적으로 허용되는 염의 사용.
  6. 제1항 기재의 테르피리딘 유도체 또는 그의 약학적으로 허용되는 유효량을 사람에게 투여하는 것으로 된 신경변성질환의 개선 또는 치료법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019950702396A 1992-12-28 1993-12-28 테르피리딘 유도체의 약학적 용도 KR950703955A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP348684/1992 1992-12-28
JP34868492 1992-12-28
PCT/JP1993/001921 WO1994014440A1 (en) 1992-12-28 1993-12-28 Pharmaceutical use of terpyridine derivative

Publications (1)

Publication Number Publication Date
KR950703955A true KR950703955A (ko) 1995-11-17

Family

ID=18398665

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950702396A KR950703955A (ko) 1992-12-28 1993-12-28 테르피리딘 유도체의 약학적 용도

Country Status (5)

Country Link
EP (1) EP0677293A4 (ko)
KR (1) KR950703955A (ko)
AU (1) AU5717394A (ko)
CA (1) CA2152777A1 (ko)
WO (1) WO1994014440A1 (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3884476B2 (ja) * 1994-06-24 2007-02-21 大正製薬株式会社 ピリジン誘導体
CN1087015C (zh) * 1994-11-28 2002-07-03 大正制药株式会社 吡啶衍生物
KR100851608B1 (ko) * 2001-08-08 2008-08-12 영남대학교 산학협력단 터피리딘의 유도체, 이의 제조방법 및 이를 함유하는 항암제
FR2895409A1 (fr) * 2005-12-23 2007-06-29 Commissariat Energie Atomique Complexes sensibilisateurs, leur procede de preparation, materiau hybride inorganique-organique semiconducteur les comprenant, et cellule photovoltaique comprenant ce materiau
CN108424382B (zh) * 2018-02-27 2022-04-22 广东医科大学 一种3,3’-双取代联吡啶衍生物及其制备方法和应用
US11912662B1 (en) 2023-10-13 2024-02-27 King Faisal University 2-alkoxy[4,3:6,2-terpyridine]-3-carbonitrile as antimicrobial compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62168141A (ja) * 1986-01-20 1987-07-24 Konishiroku Photo Ind Co Ltd ハロゲン化銀カラ−感光材料
JPS63168644A (ja) * 1987-01-06 1988-07-12 Konica Corp 保存性に優れたハロゲン化銀写真感光材料
JPH02135365A (ja) * 1988-11-16 1990-05-24 Canon Inc 電子写真用現像剤
US5367080A (en) * 1990-11-08 1994-11-22 Sterling Winthrop Inc. Complexing agents and targeting radioactive immunoreagents useful in therapeutic and diagnostic imaging compositions and methods

Also Published As

Publication number Publication date
EP0677293A1 (en) 1995-10-18
WO1994014440A1 (en) 1994-07-07
AU5717394A (en) 1994-07-19
CA2152777A1 (en) 1994-07-07
EP0677293A4 (en) 1996-02-28

Similar Documents

Publication Publication Date Title
KR890003731A (ko) 인돌 유도체
NO20022264L (no) Farmasoytisk blanding inneholdende tolterodin, samt anvendelse derav
KR890701559A (ko) 3-인돌피루브산 유도체 및 그의 제약 용도
ATE219363T1 (de) Lösliche prodrugs von paclitaxel
LV12766A (lv) Composition of l-dopa esters
KR910009272A (ko) 메일라아드 반응의 억제를 위한 제약조성물 및 방법
KR890005124A (ko) 세펨 화합물 및 이의 제조방법
KR940005274A (ko) 쇼그렌(Sjoegren)증후군 치료제
TNSN05080A1 (en) NOVEL ANTIMYCOBACTERIAL COMPOUNDS (as filed) AND PYRROLE DERIVATIVES AS ANTIMYCOBACTERIAL COMPOUNDS (as published)
NO303265B1 (no) Xantinderivater samt anvendelse av xantinderivater for fremstilling av et terapeutisk middel mot Parkinson's sykdom
KR910015562A (ko) 뇌부전 질환치료용 약제, 신규 2-(1-피페라지닐)-4-페닐시클로알카노 피리미딘 유도체, 및 그의 제법
RU94046141A (ru) Замещенные производные /арилалкоксибензил/ аминопропанамида, способы их получения, фармацевтическая композиция
KR950703955A (ko) 테르피리딘 유도체의 약학적 용도
KR890005036A (ko) 아미드화합물, 이들의 제조방법 및 이들 화합물을 함유하여 위신경기능을 활성화하는 조성물
KR900700098A (ko) 발기부전의 치료겸 진단용 플라복세이트 및 그 유도체
KR950032171A (ko) 옥소피리디닐퀴녹살린 유도체
DE69222570D1 (de) Phosphonsäurederivate, Verfahren zur Herstellung und ihre Verwendung
KR930017882A (ko) 아미노 벤조산 유도체
KR910016691A (ko) 신규한 치환된-아민 화합물 및 그의 제조방법
SE9302333D0 (sv) New compounds
KR930019212A (ko) 피소스티그민 유도체와 이의 용도 및 이를 함유한 제약적 조제물
HUP0302255A2 (hu) Szulfonamidszármazékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
KR950008502A (ko) 3-또는4-클리코실옥시벤조피란 유도체 및 활성 성분으로서 이를 함유하는 알러지치료제
ATE81130T1 (de) 4,5,6,7-tetrahydroisothiazolo (4,5-c)pyridinderivate und isomere.
WO1990011080A1 (fr) Medicament ameliorant les fonctions cerebrales

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid